Fairbanks welcomes its newest employee Alden Richter to our growing company. Alden is currently a Massachusetts Life Science Center intern and just finished his Master’s Degree Program in Applied Molecular Biology at University of Massachusetts – Amherst. His project for the Master’s program was focused on cloning and expressing canine FSTL3 and he is continuing that work as an intern at Fairbanks. He is also using his biotechnology skills to express recombinant versions of our top candidate antibody therapies.
Alden completed his undergraduate degree in Microbiology at University of Massachusetts – Amherst in May 2018. Prior to entering college, Alden served in the US Army as a combat engineer including a tour in Afghanistan.
The addition of Alden will allow us to expand our research and development of diabetes therapies to include companion animal diabetes treatments. Cloning dog and cat FSTL3 and expressing protein is the first step in the process and we are excited to have Alden’s expertise which will accelerate progress on this project.